PSYD_0302: BIRMINGHAM

This record is part of the Psy-ShareD database. The Psy-ShareD database will host pre-existing structural MRI data collected at different global sites that will be suitable for region of interest, voxel-based morphometry, cortical thickness and surface area analytical approaches. To access this database, complete the Data Access Request Form by following the link on this page under the Licence ‘Psy-ShareD Data Access Request’. For more information, follow the link listed in Related Materials.
A randomised, double-blind, placebo-controlled trial in participants with a recent-onset schizophrenia-spectrum disorder with continuing positive symptoms.
Contributors and PIs: John F. W. Deakin
Neuroscience and Psychiatry Unit, The University of Manchester, Manchester, UK
Institute for Mental Health and Centre for Human Brain Health, University of Birmingham, Birmingham, UK
Key Details & Variables
Data Type
Image data/Feature data
Age Range
19-34
Number of Participants
28
Diagnostic Criteria
SCZ
Number of Clinical Subjects
18
Number of Clinical Subjects (follow-up)
10
Number of Control Subjects
N/A
Number of Control Subjects (follow-up)
N/A
Demographic Information
Age, Sex, Ethnicity, Handedness, Education
Clinical Measures
PANSS, CDSS, EPS, MAH, COO
Cognitive Measures
N/A
Clinical Functioning Measures
GAF
Antipsychotic Medication Information Recorded
Yes
Antipsychotic Medication Name/ Antipsychotic Type
Name
Antipsychotic Dose Recorded
Yes
CPZ Equivalents Recorded
N/A
Other Medication Variables Recorded
Yes
Recreational Drug/ Alcohol Use
Yes
Note: the above table features key details and variables and is not an exhaustive list.